Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

1. Fellström, B.C.
2. Barratt, J.
3. Cook, H.
4. Coppo, R.
5. Feehally, J.
6. de Fijter, J.W.
7. Floege, J.
8. Hetzel, G.
9. Jardine, A.G.
10. Locatelli, F.
11. Maes, B.D.
12. Mercer, A.
13. Ortiz, F.
14. Praga, M.
15. Sørensen, S.S.
16. Tesar, V.
17. Del Vecchio, L.